VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer

Colorectal Cancer MORE >>

In the first report of the full cohort of 119 patients in the CheckMate-142 study, positive results were demonstrated with nivolumab alone or in combination with ipilimumab in patients with previously treated microsatellite instability-high or DNA mismatch repair-deficient metastatic colorectal cancer.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.